6550--DNA Extraction Reagents
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs, Network Contracting Office 23, has awarded a Firm Fixed-Price contract to PROMEGA CORPORATION for DNA Extraction Reagents for the Minneapolis VA Health Care System. The award, under solicitation number 36C26326R0054, is valued at $124,143.07.
Scope of Work
This award procures Promega branded DNA Extraction Reagents specifically for the Minneapolis VA Health Care System (MVAHCS). These reagents are essential for DNA extraction and quantification using existing Promega Maxwell® RSC and 48 RSC DNA extractors and the Promega Quantus™ fluorometer. The reagents support various high-level molecular testing, including JAK2, Hereditary Hemochromatosis, Myeloid Panel, Solid Tumor Panel, and LUNG RT-48 testing. Key deliverables included specific Promega kits (e.g., Maxwell® RSC Blood DNA, Maxwell® RSC RNA FFPE Kit, Maxwell® RSC DNA FFPE Kit, QuantiFluor® ONE dsDNA System).
Contract Details
- Awardee: PROMEGA CORPORATION
- Award Value: $124,143.07
- Award Date: June 1, 2026
- Contract Type: Firm Fixed-Price
- Solicitation Number: 36C26326R0054
- Set-Aside: Full and Open Competition
- Product Service Code: 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets)
- NAICS Code: 325413 (In-Vitro Diagnostic Substance Manufacturing)
- Periods of Performance:
- Base Period: June 1, 2026 - September 30, 2026
- Option Period 1: October 1, 2026 - September 30, 2027
- Option Period 2: October 1, 2027 - September 30, 2028
- Option Period 3: October 1, 2028 - September 30, 2029
- Option Period 4: October 1, 2029 - September 30, 2030
- Place of Performance: Minneapolis VA Health Care System, One Veterans Drive, Minneapolis, MN 55417, USA.
Justification & Evaluation
The procurement was justified as a Brand Name Only requirement for Promega Corporation products. This was due to the proprietary nature of the reagents, which are exclusively compatible with the MVAHCS's existing Promega Maxwell RSC and Quantus TM fluorometer equipment, previously acquired under a sole-source contract. The original solicitation was evaluated using a Lowest Price Technically Acceptable (LPTA) process.
Contact Information
Robert Bennett, Contract Specialist, robert.bennett8@va.gov, 319-339-7079.